TLR agonist rMBP-NAP inhibits B16 melanoma tumor growth via induction of DCs maturation and T-cells cytotoxic response
Article in Cytotechnology (July 2022)
The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.
Article in Cytotechnology (July 2022)
Article in Cancers (June 2022)
Article in Vacunas (English Edition) (May 2022)